HISTOPLASMOSIS CUTANEOUS

HISTOPLASMOSIS CUTANEOUS was reported 48 times

HISTOPLASMOSIS CUTANEOUS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Chemokine Receptor Type 4 Interaction [EPC] 1 0.0007
1 Antimetabolite Immunosuppressant [EPC] 10 0.0005
2 Lipid-based Polyene Antifungal [EPC] 4 0.0003
3 Peroxisome Proliferator Receptor alpha Agonist [EPC] 10 0.0002
4 Polyene Antifungal [EPC] 4 0.0001
5 Antirheumatic Agent [EPC] 9 0.0001
6 Human Immunoglobulin G [EPC] 1 0.0000
7 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
8 Interleukin-6 Receptor Antagonist [EPC] 5 0.0000
9 Interleukin-17A Antagonist [EPC] 1 0.0000
10 Corticosteroid [EPC] 34 0.0000
11 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
12 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
13 Azole Antifungal [EPC] 3 0.0000
14 Tumor Necrosis Factor Blocker [EPC] 12 0.0000
15 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
16 Purine Antimetabolite [EPC] 1 0.0000
17 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
18 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
19 Estrogen [EPC] 1 0.0000
20 Thiazide Diuretic [EPC] 1 0.0000
21 Vitamin D [EPC] 1 0.0000
22 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
23 Vitamin B12 [EPC] 1 0.0000
24 Benzodiazepine [EPC] 2 0.0000
25 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
26 Vitamin C [EPC] 1 0.0000
27 Thalidomide Analog [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000